GURUFOCUS.COM » STOCK LIST » Technology » Software » Cellgentek Co Ltd (XKRX:258250) » Definitions » Current Deferred Revenue

Cellgentek Co (XKRX:258250) Current Deferred Revenue : ₩0 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Cellgentek Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Cellgentek Co's current deferred revenue for the quarter that ended in Dec. 2023 was ₩0 Mil.

Cellgentek Co Current Deferred Revenue Historical Data

The historical data trend for Cellgentek Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellgentek Co Current Deferred Revenue Chart

Cellgentek Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
- - - - -

Cellgentek Co Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue - - - - -

Cellgentek Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Cellgentek Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellgentek Co Business Description

Traded in Other Exchanges
N/A
Address
579-4 Yuseong-daero, Yuseong-gu, Daejeon, KOR
Cellgentek Co Ltd is engaged in provision of information technology services for IT venture companies including computer, IT software development and franchise business. It is also engaged in development of drugs.

Cellgentek Co Headlines

No Headlines